nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Epirubicin—bone cancer	0.839	1	CbGbCtD
Carbachol—Venous thrombosis—Carboplatin—bone cancer	0.0125	0.0851	CcSEcCtD
Carbachol—Fluid overload—Carboplatin—bone cancer	0.0108	0.0738	CcSEcCtD
Carbachol—Gastrointestinal ulcer haemorrhage—Cisplatin—bone cancer	0.0103	0.0702	CcSEcCtD
Carbachol—Extravasation—Carboplatin—bone cancer	0.00771	0.0526	CcSEcCtD
Carbachol—PLA2G4A—Raltitrexed—Methotrexate—bone cancer	0.00695	1	CbGdCrCtD
Carbachol—Phlebitis—Carboplatin—bone cancer	0.00566	0.0387	CcSEcCtD
Carbachol—Gastrointestinal ulcer haemorrhage—Methotrexate—bone cancer	0.00564	0.0385	CcSEcCtD
Carbachol—Venous thrombosis—Cisplatin—bone cancer	0.00365	0.0249	CcSEcCtD
Carbachol—Fluid overload—Cisplatin—bone cancer	0.00317	0.0217	CcSEcCtD
Carbachol—Necrosis—Cisplatin—bone cancer	0.00251	0.0172	CcSEcCtD
Carbachol—Abscess—Cisplatin—bone cancer	0.00249	0.017	CcSEcCtD
Carbachol—Infection—Carboplatin—bone cancer	0.00238	0.0163	CcSEcCtD
Carbachol—Tenderness—Cisplatin—bone cancer	0.00226	0.0154	CcSEcCtD
Carbachol—Extravasation—Cisplatin—bone cancer	0.00226	0.0154	CcSEcCtD
Carbachol—Ulcer—Cisplatin—bone cancer	0.00208	0.0142	CcSEcCtD
Carbachol—Pain—Carboplatin—bone cancer	0.00205	0.014	CcSEcCtD
Carbachol—Hyperkalaemia—Cisplatin—bone cancer	0.00194	0.0132	CcSEcCtD
Carbachol—Body temperature increased—Carboplatin—bone cancer	0.0019	0.0129	CcSEcCtD
Carbachol—Venous thrombosis—Epirubicin—bone cancer	0.00188	0.0128	CcSEcCtD
Carbachol—Venous thrombosis—Doxorubicin—bone cancer	0.00174	0.0119	CcSEcCtD
Carbachol—Phlebitis—Cisplatin—bone cancer	0.00166	0.0113	CcSEcCtD
Carbachol—Hyponatraemia—Cisplatin—bone cancer	0.00144	0.00981	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.00143	0.00978	CcSEcCtD
Carbachol—Necrosis—Methotrexate—bone cancer	0.00138	0.00941	CcSEcCtD
Carbachol—Abscess—Methotrexate—bone cancer	0.00137	0.00934	CcSEcCtD
Carbachol—Necrosis—Epirubicin—bone cancer	0.00129	0.00881	CcSEcCtD
Carbachol—Cramp muscle—Cisplatin—bone cancer	0.00129	0.0088	CcSEcCtD
Carbachol—Abscess—Epirubicin—bone cancer	0.00128	0.00874	CcSEcCtD
Carbachol—Stinging—Epirubicin—bone cancer	0.00125	0.00854	CcSEcCtD
Carbachol—Extravasation—Methotrexate—bone cancer	0.00124	0.00847	CcSEcCtD
Carbachol—Sweating increased—Cisplatin—bone cancer	0.00121	0.00823	CcSEcCtD
Carbachol—Necrosis—Doxorubicin—bone cancer	0.00119	0.00815	CcSEcCtD
Carbachol—Abdominal discomfort—Cisplatin—bone cancer	0.00119	0.0081	CcSEcCtD
Carbachol—Abscess—Doxorubicin—bone cancer	0.00118	0.00809	CcSEcCtD
Carbachol—Extravasation—Epirubicin—bone cancer	0.00116	0.00793	CcSEcCtD
Carbachol—Stinging—Doxorubicin—bone cancer	0.00116	0.0079	CcSEcCtD
Carbachol—Ulcer—Methotrexate—bone cancer	0.00114	0.00781	CcSEcCtD
Carbachol—Extravasation—Doxorubicin—bone cancer	0.00107	0.00733	CcSEcCtD
Carbachol—Ulcer—Epirubicin—bone cancer	0.00107	0.00731	CcSEcCtD
Carbachol—Hyperkalaemia—Epirubicin—bone cancer	0.000995	0.00679	CcSEcCtD
Carbachol—Ulcer—Doxorubicin—bone cancer	0.000991	0.00676	CcSEcCtD
Carbachol—Salivary hypersecretion—Epirubicin—bone cancer	0.000983	0.00672	CcSEcCtD
Carbachol—Hyperkalaemia—Doxorubicin—bone cancer	0.000921	0.00629	CcSEcCtD
Carbachol—Flushing—Cisplatin—bone cancer	0.000919	0.00628	CcSEcCtD
Carbachol—Salivary hypersecretion—Doxorubicin—bone cancer	0.00091	0.00621	CcSEcCtD
Carbachol—Arrhythmia—Cisplatin—bone cancer	0.000885	0.00604	CcSEcCtD
Carbachol—Phlebitis—Epirubicin—bone cancer	0.000853	0.00583	CcSEcCtD
Carbachol—Flatulence—Cisplatin—bone cancer	0.000849	0.0058	CcSEcCtD
Carbachol—Muscle spasms—Cisplatin—bone cancer	0.000829	0.00566	CcSEcCtD
Carbachol—Phlebitis—Doxorubicin—bone cancer	0.00079	0.00539	CcSEcCtD
Carbachol—Hyponatraemia—Epirubicin—bone cancer	0.000738	0.00504	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000735	0.00502	CcSEcCtD
Carbachol—Infection—Cisplatin—bone cancer	0.000699	0.00477	CcSEcCtD
Carbachol—Hyponatraemia—Doxorubicin—bone cancer	0.000683	0.00466	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00068	0.00464	CcSEcCtD
Carbachol—Hyperhidrosis—Cisplatin—bone cancer	0.00068	0.00464	CcSEcCtD
Carbachol—Asthma—Methotrexate—bone cancer	0.000679	0.00464	CcSEcCtD
Carbachol—Hypotension—Cisplatin—bone cancer	0.000657	0.00449	CcSEcCtD
Carbachol—Abdominal discomfort—Methotrexate—bone cancer	0.000651	0.00444	CcSEcCtD
Carbachol—Asthma—Epirubicin—bone cancer	0.000635	0.00434	CcSEcCtD
Carbachol—Pain—Cisplatin—bone cancer	0.000602	0.00411	CcSEcCtD
Carbachol—Asthma—Doxorubicin—bone cancer	0.000588	0.00401	CcSEcCtD
Carbachol—Sweating—Methotrexate—bone cancer	0.00058	0.00396	CcSEcCtD
Carbachol—Body temperature increased—Cisplatin—bone cancer	0.000556	0.0038	CcSEcCtD
Carbachol—Sweating—Epirubicin—bone cancer	0.000543	0.00371	CcSEcCtD
Carbachol—Sweating—Doxorubicin—bone cancer	0.000503	0.00343	CcSEcCtD
Carbachol—Diarrhoea—Cisplatin—bone cancer	0.000481	0.00329	CcSEcCtD
Carbachol—Flushing—Epirubicin—bone cancer	0.000472	0.00322	CcSEcCtD
Carbachol—CHRM3—Acetylcholine regulates insulin secretion—GNA11—bone cancer	0.000471	0.0595	CbGpPWpGaD
Carbachol—Arrhythmia—Epirubicin—bone cancer	0.000454	0.0031	CcSEcCtD
Carbachol—Vomiting—Cisplatin—bone cancer	0.000447	0.00305	CcSEcCtD
Carbachol—Rash—Cisplatin—bone cancer	0.000444	0.00303	CcSEcCtD
Carbachol—Dermatitis—Cisplatin—bone cancer	0.000443	0.00303	CcSEcCtD
Carbachol—Flushing—Doxorubicin—bone cancer	0.000437	0.00298	CcSEcCtD
Carbachol—Flatulence—Epirubicin—bone cancer	0.000436	0.00298	CcSEcCtD
Carbachol—Muscle spasms—Epirubicin—bone cancer	0.000426	0.00291	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—bone cancer	0.00042	0.00287	CcSEcCtD
Carbachol—Nausea—Cisplatin—bone cancer	0.000418	0.00285	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—bone cancer	0.000404	0.00276	CcSEcCtD
Carbachol—Syncope—Epirubicin—bone cancer	0.000397	0.00271	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—bone cancer	0.000394	0.00269	CcSEcCtD
Carbachol—Loss of consciousness—Epirubicin—bone cancer	0.000389	0.00266	CcSEcCtD
Carbachol—Infection—Methotrexate—bone cancer	0.000384	0.00262	CcSEcCtD
Carbachol—PLA2G4A—ADP signalling through P2Y purinoceptor 1—GNA11—bone cancer	0.000377	0.0477	CbGpPWpGaD
Carbachol—Hyperhidrosis—Methotrexate—bone cancer	0.000373	0.00255	CcSEcCtD
Carbachol—Syncope—Doxorubicin—bone cancer	0.000367	0.00251	CcSEcCtD
Carbachol—Hypotension—Methotrexate—bone cancer	0.000361	0.00246	CcSEcCtD
Carbachol—Loss of consciousness—Doxorubicin—bone cancer	0.00036	0.00246	CcSEcCtD
Carbachol—Infection—Epirubicin—bone cancer	0.000359	0.00245	CcSEcCtD
Carbachol—Shock—Epirubicin—bone cancer	0.000355	0.00243	CcSEcCtD
Carbachol—Hyperhidrosis—Epirubicin—bone cancer	0.000349	0.00239	CcSEcCtD
Carbachol—Dyspepsia—Methotrexate—bone cancer	0.00034	0.00232	CcSEcCtD
Carbachol—Hypotension—Epirubicin—bone cancer	0.000338	0.00231	CcSEcCtD
Carbachol—Infection—Doxorubicin—bone cancer	0.000332	0.00227	CcSEcCtD
Carbachol—Pain—Methotrexate—bone cancer	0.00033	0.00225	CcSEcCtD
Carbachol—Shock—Doxorubicin—bone cancer	0.000329	0.00225	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—bone cancer	0.000323	0.00221	CcSEcCtD
Carbachol—Dyspepsia—Epirubicin—bone cancer	0.000318	0.00217	CcSEcCtD
Carbachol—PLA2G4A—Signal amplification—GNA11—bone cancer	0.000318	0.0402	CbGpPWpGaD
Carbachol—Hypotension—Doxorubicin—bone cancer	0.000312	0.00213	CcSEcCtD
Carbachol—Pain—Epirubicin—bone cancer	0.000309	0.00211	CcSEcCtD
Carbachol—Abdominal pain—Methotrexate—bone cancer	0.000305	0.00208	CcSEcCtD
Carbachol—Body temperature increased—Methotrexate—bone cancer	0.000305	0.00208	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—bone cancer	0.000294	0.00201	CcSEcCtD
Carbachol—Pain—Doxorubicin—bone cancer	0.000286	0.00195	CcSEcCtD
Carbachol—Abdominal pain—Epirubicin—bone cancer	0.000286	0.00195	CcSEcCtD
Carbachol—Body temperature increased—Epirubicin—bone cancer	0.000286	0.00195	CcSEcCtD
Carbachol—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.000268	0.0339	CbGpPWpGaD
Carbachol—Body temperature increased—Doxorubicin—bone cancer	0.000264	0.0018	CcSEcCtD
Carbachol—Abdominal pain—Doxorubicin—bone cancer	0.000264	0.0018	CcSEcCtD
Carbachol—Diarrhoea—Methotrexate—bone cancer	0.000264	0.0018	CcSEcCtD
Carbachol—Dizziness—Methotrexate—bone cancer	0.000255	0.00174	CcSEcCtD
Carbachol—Diarrhoea—Epirubicin—bone cancer	0.000247	0.00169	CcSEcCtD
Carbachol—Vomiting—Methotrexate—bone cancer	0.000245	0.00168	CcSEcCtD
Carbachol—Rash—Methotrexate—bone cancer	0.000243	0.00166	CcSEcCtD
Carbachol—Dermatitis—Methotrexate—bone cancer	0.000243	0.00166	CcSEcCtD
Carbachol—Headache—Methotrexate—bone cancer	0.000242	0.00165	CcSEcCtD
Carbachol—Dizziness—Epirubicin—bone cancer	0.000239	0.00163	CcSEcCtD
Carbachol—CHRM2—SIDS Susceptibility Pathways—FEV—bone cancer	0.000237	0.03	CbGpPWpGaD
Carbachol—Vomiting—Epirubicin—bone cancer	0.00023	0.00157	CcSEcCtD
Carbachol—Nausea—Methotrexate—bone cancer	0.000229	0.00157	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—bone cancer	0.000229	0.00156	CcSEcCtD
Carbachol—Rash—Epirubicin—bone cancer	0.000228	0.00156	CcSEcCtD
Carbachol—Dermatitis—Epirubicin—bone cancer	0.000228	0.00155	CcSEcCtD
Carbachol—Headache—Epirubicin—bone cancer	0.000226	0.00155	CcSEcCtD
Carbachol—Dizziness—Doxorubicin—bone cancer	0.000221	0.00151	CcSEcCtD
Carbachol—Nausea—Epirubicin—bone cancer	0.000215	0.00147	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—bone cancer	0.000213	0.00145	CcSEcCtD
Carbachol—Rash—Doxorubicin—bone cancer	0.000211	0.00144	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—bone cancer	0.000211	0.00144	CcSEcCtD
Carbachol—Headache—Doxorubicin—bone cancer	0.000209	0.00143	CcSEcCtD
Carbachol—Nausea—Doxorubicin—bone cancer	0.000199	0.00136	CcSEcCtD
Carbachol—PLA2G4A—Endothelins—GNA11—bone cancer	0.00018	0.0228	CbGpPWpGaD
Carbachol—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000131	0.0166	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000126	0.016	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Other—GRM1—bone cancer	0.000125	0.0158	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Other—GRM1—bone cancer	0.000124	0.0156	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	0.000116	0.0146	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000104	0.0132	CbGpPWpGaD
Carbachol—CHRM1—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	9.73e-05	0.0123	CbGpPWpGaD
Carbachol—CHRM3—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	9.7e-05	0.0123	CbGpPWpGaD
Carbachol—CHRM2—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	9.61e-05	0.0121	CbGpPWpGaD
Carbachol—PLA2G4A—PDGF Pathway—JUN—bone cancer	9.58e-05	0.0121	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	9.54e-05	0.0121	CbGpPWpGaD
Carbachol—CHRM3—Regulation of insulin secretion—GNA11—bone cancer	9.19e-05	0.0116	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Other—SMO—bone cancer	8.79e-05	0.0111	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Other—SMO—bone cancer	8.71e-05	0.011	CbGpPWpGaD
Carbachol—PLA2G4A—Arachidonic acid metabolism—PTGS2—bone cancer	8.71e-05	0.011	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—MMP2—bone cancer	8.14e-05	0.0103	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	8.11e-05	0.0103	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	7.39e-05	0.00934	CbGpPWpGaD
Carbachol—CHRM3—Integration of energy metabolism—GNA11—bone cancer	7.23e-05	0.00914	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—SPARC—bone cancer	7.22e-05	0.00912	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—GRM1—bone cancer	7.04e-05	0.00889	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—GRM1—bone cancer	7.01e-05	0.00887	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	6.89e-05	0.00871	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.73e-05	0.0085	CbGpPWpGaD
Carbachol—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—JUN—bone cancer	6.7e-05	0.00846	CbGpPWpGaD
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	6.68e-05	0.00844	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—GRM4—bone cancer	6.67e-05	0.00844	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—RGS1—bone cancer	6.67e-05	0.00844	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.63e-05	0.00839	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—GNA11—bone cancer	6.6e-05	0.00834	CbGpPWpGaD
Carbachol—PLA2G4A—Endothelins—JUN—bone cancer	6.53e-05	0.00825	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	6.29e-05	0.00796	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—JUN—bone cancer	6.29e-05	0.00795	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	6.27e-05	0.00793	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—MMP9—bone cancer	6.12e-05	0.00773	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—IL3—bone cancer	5.99e-05	0.00756	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.62e-05	0.00711	CbGpPWpGaD
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	5.6e-05	0.00707	CbGpPWpGaD
Carbachol—CHRM1—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	5.44e-05	0.00687	CbGpPWpGaD
Carbachol—CHRM3—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	5.42e-05	0.00685	CbGpPWpGaD
Carbachol—CHRM2—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	5.37e-05	0.00679	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—BRAF—bone cancer	5.18e-05	0.00655	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—BRAF—bone cancer	5.02e-05	0.00635	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—EGFR—bone cancer	4.94e-05	0.00625	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—GNA11—bone cancer	4.53e-05	0.00573	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—GNA11—bone cancer	4.52e-05	0.00571	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—NDUFA12—bone cancer	4.38e-05	0.00554	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—GNA11—bone cancer	4.28e-05	0.00541	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—EZH2—bone cancer	4.26e-05	0.00539	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—MDM2—bone cancer	4.21e-05	0.00532	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.17e-05	0.00527	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—GRM4—bone cancer	4.09e-05	0.00517	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—GRM4—bone cancer	4.08e-05	0.00516	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	4.06e-05	0.00513	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	4.04e-05	0.00511	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—GRM4—bone cancer	4.04e-05	0.00511	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—BRAF—bone cancer	3.85e-05	0.00486	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—JUN—bone cancer	3.77e-05	0.00477	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—SPARC—bone cancer	3.72e-05	0.0047	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—NT5C3A—bone cancer	3.63e-05	0.00459	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—GRM1—bone cancer	3.55e-05	0.00449	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—GRM1—bone cancer	3.54e-05	0.00447	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—GRM1—bone cancer	3.5e-05	0.00443	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—RGS1—bone cancer	3.5e-05	0.00442	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—GRM4—bone cancer	3.5e-05	0.00442	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—GNA11—bone cancer	3.4e-05	0.0043	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—MDM2—bone cancer	3.22e-05	0.00407	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.09e-05	0.00391	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—IL3—bone cancer	3.09e-05	0.0039	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—GRM1—bone cancer	3.03e-05	0.00383	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.98e-05	0.00377	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—BRAF—bone cancer	2.7e-05	0.00342	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—BRAF—bone cancer	2.7e-05	0.00341	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.69e-05	0.0034	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—BRAF—bone cancer	2.67e-05	0.00337	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—NDUFA12—bone cancer	2.63e-05	0.00332	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—SMO—bone cancer	2.5e-05	0.00316	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—SMO—bone cancer	2.49e-05	0.00315	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—SMO—bone cancer	2.47e-05	0.00312	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—CDK4—bone cancer	2.41e-05	0.00304	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—RGS1—bone cancer	2.31e-05	0.00292	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—GRM4—bone cancer	2.31e-05	0.00292	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—GRM4—bone cancer	2.31e-05	0.00291	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—RGS1—bone cancer	2.31e-05	0.00291	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—GRM4—bone cancer	2.28e-05	0.00289	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—RGS1—bone cancer	2.28e-05	0.00289	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—NT5C3A—bone cancer	2.18e-05	0.00275	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—SMO—bone cancer	2.14e-05	0.0027	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.11e-05	0.00267	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—GRM4—bone cancer	2.1e-05	0.00266	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—RGS1—bone cancer	2.1e-05	0.00266	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—RGS1—bone cancer	2.09e-05	0.00265	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—GRM4—bone cancer	2.09e-05	0.00265	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—GRM4—bone cancer	2.07e-05	0.00262	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—RGS1—bone cancer	2.07e-05	0.00262	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RGS1—bone cancer	2.06e-05	0.00261	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—GRM4—bone cancer	2.06e-05	0.00261	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—PLAU—bone cancer	2.02e-05	0.00256	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—GRM1—bone cancer	2.01e-05	0.00254	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—GRM1—bone cancer	2e-05	0.00253	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—GRM1—bone cancer	1.98e-05	0.0025	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—GNA11—bone cancer	1.95e-05	0.00247	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—JUN—bone cancer	1.87e-05	0.00237	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—GRM1—bone cancer	1.82e-05	0.0023	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—GRM1—bone cancer	1.82e-05	0.00229	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—GRM1—bone cancer	1.8e-05	0.00227	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—GRM1—bone cancer	1.79e-05	0.00226	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.77e-05	0.00224	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL3—bone cancer	1.77e-05	0.00224	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ENO2—bone cancer	1.59e-05	0.00201	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—JUN—bone cancer	1.55e-05	0.00196	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	1.55e-05	0.00196	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—EGFR—bone cancer	1.54e-05	0.00195	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	1.53e-05	0.00193	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—DHFR—bone cancer	1.48e-05	0.00187	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GNA11—bone cancer	1.38e-05	0.00174	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—GNA11—bone cancer	1.29e-05	0.00163	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—GNA11—bone cancer	1.29e-05	0.00163	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—SMO—bone cancer	1.28e-05	0.00162	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—SMO—bone cancer	1.28e-05	0.00162	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—GNA11—bone cancer	1.28e-05	0.00161	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—SMO—bone cancer	1.27e-05	0.0016	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SMO—bone cancer	1.26e-05	0.00159	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CYP3A4—bone cancer	1.25e-05	0.00158	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.24e-05	0.00157	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GRM4—bone cancer	1.24e-05	0.00157	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RGS1—bone cancer	1.24e-05	0.00157	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GRM4—bone cancer	1.24e-05	0.00156	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RGS1—bone cancer	1.24e-05	0.00156	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GRM4—bone cancer	1.22e-05	0.00155	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RGS1—bone cancer	1.22e-05	0.00155	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—GNA11—bone cancer	1.17e-05	0.00148	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—IL3—bone cancer	1.17e-05	0.00148	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—GNA11—bone cancer	1.17e-05	0.00148	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—IL3—bone cancer	1.17e-05	0.00148	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—GNA11—bone cancer	1.16e-05	0.00146	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—IL3—bone cancer	1.16e-05	0.00146	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	1.15e-05	0.00146	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—GNA11—bone cancer	1.15e-05	0.00146	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	1.15e-05	0.00146	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GRM1—bone cancer	1.08e-05	0.00136	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ATF1—bone cancer	1.07e-05	0.00136	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GRM1—bone cancer	1.07e-05	0.00136	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GSTP1—bone cancer	1.07e-05	0.00135	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL3—bone cancer	1.06e-05	0.00134	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GRM1—bone cancer	1.06e-05	0.00134	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL3—bone cancer	1.06e-05	0.00134	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL3—bone cancer	1.05e-05	0.00133	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL3—bone cancer	1.05e-05	0.00132	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—TP53—bone cancer	1.02e-05	0.00129	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ENO2—bone cancer	9.53e-06	0.0012	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TGFBR2—bone cancer	8.95e-06	0.00113	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—DHFR—bone cancer	8.84e-06	0.00112	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IGF1R—bone cancer	8.42e-06	0.00106	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GNA11—bone cancer	8.27e-06	0.00104	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—TP53—bone cancer	8.14e-06	0.00103	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SMO—bone cancer	7.58e-06	0.000958	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SMO—bone cancer	7.56e-06	0.000955	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CYP3A4—bone cancer	7.49e-06	0.000947	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SMO—bone cancer	7.48e-06	0.000946	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GNA11—bone cancer	6.93e-06	0.000876	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GNA11—bone cancer	6.91e-06	0.000874	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GNA11—bone cancer	6.84e-06	0.000865	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ATF1—bone cancer	6.45e-06	0.000815	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ATF1—bone cancer	6.43e-06	0.000812	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GSTP1—bone cancer	6.41e-06	0.00081	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ATF1—bone cancer	6.36e-06	0.000804	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL3—bone cancer	6.29e-06	0.000794	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL3—bone cancer	6.27e-06	0.000792	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL3—bone cancer	6.2e-06	0.000784	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KIT—bone cancer	6.1e-06	0.000771	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—BRAF—bone cancer	5.74e-06	0.000725	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—EGFR—bone cancer	5.56e-06	0.000703	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTGS2—bone cancer	5.54e-06	0.000701	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TGFBR2—bone cancer	5.38e-06	0.000679	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TGFBR2—bone cancer	5.36e-06	0.000677	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TGFBR2—bone cancer	5.31e-06	0.000671	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1R—bone cancer	5.06e-06	0.000639	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1R—bone cancer	5.04e-06	0.000637	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1R—bone cancer	4.99e-06	0.000631	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MDM2—bone cancer	4.81e-06	0.000608	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—JUN—bone cancer	4.18e-06	0.000528	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MMP9—bone cancer	4.07e-06	0.000514	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KIT—bone cancer	3.67e-06	0.000464	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KIT—bone cancer	3.66e-06	0.000462	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KIT—bone cancer	3.62e-06	0.000458	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—BRAF—bone cancer	3.45e-06	0.000436	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—BRAF—bone cancer	3.44e-06	0.000434	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—BRAF—bone cancer	3.4e-06	0.00043	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—EGFR—bone cancer	3.34e-06	0.000422	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—EGFR—bone cancer	3.33e-06	0.000421	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTGS2—bone cancer	3.32e-06	0.00042	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—EGFR—bone cancer	3.3e-06	0.000417	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EGFR—bone cancer	3.29e-06	0.000415	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MDM2—bone cancer	2.89e-06	0.000365	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MDM2—bone cancer	2.88e-06	0.000364	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MDM2—bone cancer	2.85e-06	0.00036	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TP53—bone cancer	2.76e-06	0.000349	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JUN—bone cancer	2.51e-06	0.000317	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JUN—bone cancer	2.5e-06	0.000316	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JUN—bone cancer	2.48e-06	0.000313	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP9—bone cancer	2.44e-06	0.000309	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP9—bone cancer	2.44e-06	0.000308	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP9—bone cancer	2.41e-06	0.000305	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGFR—bone cancer	1.97e-06	0.00025	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGFR—bone cancer	1.97e-06	0.000249	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGFR—bone cancer	1.95e-06	0.000246	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TP53—bone cancer	1.66e-06	0.00021	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TP53—bone cancer	1.65e-06	0.000209	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TP53—bone cancer	1.64e-06	0.000207	CbGpPWpGaD
